Most doctors don’t prescribe probiotics with antibiotics because the evidence supporting them is weaker and more complicated than most people assume. While probiotics can reduce the risk of antibiotic-associated diarrhea, the quality of that evidence is rated low, the benefits are strain-specific, and there are legitimate concerns that probiotics may actually slow your gut’s natural recovery. Add in the fact that probiotics aren’t regulated like drugs, and many physicians simply don’t feel confident enough in the products available to write a prescription for them.
The Evidence Is Real but Rated Low Quality
Probiotics do appear to help prevent diarrhea during antibiotic treatment. Meta-analyses suggest they can cut the risk of antibiotic-associated diarrhea by roughly 50%. One large analysis found that a specific yeast-based probiotic reduced diarrhea risk in adults from 17.4% to 8.2%, and in children from 20.9% to 8.8%. Another review focused on a bacterial strain showed risk dropped from 22.4% to 12.3%. Those are meaningful numbers.
The problem is that medical guidelines classify this evidence as low quality. The American Gastroenterological Association’s 2020 guidelines offer only a “conditional recommendation” for specific probiotic strains to prevent C. difficile infection during antibiotic use, noting the evidence behind it is weak. For actually treating a C. difficile infection that’s already developed, the AGA makes no recommendation at all and says probiotics should only be used in that context within a clinical trial. When the strongest professional guidelines in gastroenterology use words like “conditional” and “knowledge gap,” most doctors interpret that as insufficient grounds to prescribe.
A Cochrane review of 38 trials covering over 13,000 participants found that probiotics cut C. difficile-associated diarrhea roughly in half in relative terms. But the absolute risk reduction was small: from 3.2% down to 1.6%. Put another way, you’d need to give probiotics to 65 people to prevent a single case. For a low-risk patient on a short course of antibiotics, many doctors view that math as unconvincing.
Probiotics May Slow Your Gut’s Recovery
One of the most surprising findings in recent years came from a 2018 study published in Cell that challenged the basic assumption behind taking probiotics after antibiotics. Researchers found that after a course of antibiotics, probiotics actually colonized the gut more aggressively than they normally would, which sounds like a good thing but isn’t. That enhanced colonization came at a cost: it delayed and incomplete the return of the gut’s native microbial community.
Compared to people who recovered spontaneously (without probiotics), those who took probiotics had a “markedly delayed and persistently incomplete” restoration of their natural gut bacteria and the gene activity patterns associated with a healthy gut lining. The researchers identified that substances secreted by Lactobacillus bacteria actively inhibited the regrowth of native microbes. In other words, the probiotics were crowding out the very bacteria your gut needed to rebuild.
This finding matters because many people take probiotics specifically to “restore” their gut after antibiotics. The study suggests that your gut may actually recover faster if you leave it alone. This is the kind of counterintuitive result that makes doctors cautious about routinely recommending probiotics, even when the diarrhea prevention data looks promising.
Not All Probiotics Are the Same
One of the biggest barriers to prescribing probiotics is that the benefits are highly strain-specific. The strains with the strongest evidence for preventing antibiotic-associated diarrhea are Lactobacillus rhamnosus GG and a yeast called Saccharomyces boulardii. For preventing severe C. difficile-related diarrhea specifically, Lactobacillus casei appears most effective. Effective doses in studies ranged from 5 to 40 billion colony-forming units (CFUs) per day.
This creates a practical problem. When a doctor prescribes an antibiotic, they’re prescribing a specific molecule at a specific dose that’s been tested in rigorous clinical trials and manufactured to pharmaceutical standards. With probiotics, they’d be pointing you toward a consumer product that may or may not contain the right strain, the right dose, or even viable organisms. Most products on store shelves contain strains that have never been tested for antibiotic-associated diarrhea, and even those that list a well-studied strain may not deliver it in the quantity or viability that research supports.
Probiotics Aren’t Regulated Like Drugs
In the United States, probiotics are classified as dietary supplements, not medications. The FDA does not recognize “probiotics” as a regulatory product category at all. This means probiotic products don’t go through the approval process that drugs do, and manufacturers aren’t held to the same standards for proving their products work.
The labeling situation illustrates the problem. Within a product’s Supplement Facts panel, live microorganisms can only be listed by weight, which includes both living and dead cells. The weight doesn’t tell you how many organisms are actually alive and capable of doing anything in your gut. The FDA has acknowledged that the labeled weight “does not necessarily correlate with the number of viable microorganisms” and that live counts can decline throughout a product’s shelf life as cells die on the shelf. A draft guidance has proposed allowing CFU counts on labels to address this, but the gap between what’s in the bottle and what’s on the label remains a real concern.
For a physician, this creates an uncomfortable situation. Writing “take a probiotic” on a prescription pad isn’t like prescribing a drug where the active ingredient, dose, and quality are guaranteed. There’s no standardized probiotic product they can point to with confidence, and if something goes wrong, they’ve recommended a product they can’t fully vouch for.
Safety Concerns for Some Patients
For most healthy adults, probiotics are safe. But doctors think in terms of risk across all their patients, and certain groups face real dangers. People with weakened immune systems, whether from chemotherapy, organ transplants, HIV, or other conditions, can develop serious bloodstream infections from probiotic organisms. Lactobacillus, the most common genus in probiotic products, is rarely pathogenic in healthy people but has caused documented infections in immunocompromised patients.
Since antibiotics are frequently prescribed to people who are already sick or hospitalized, the population taking antibiotics overlaps significantly with the population most vulnerable to probiotic side effects. A blanket recommendation to pair probiotics with every antibiotic prescription would inevitably reach patients for whom probiotics pose a genuine risk.
What to Do if You Want to Try Probiotics
If you’re on antibiotics and want to reduce your chance of diarrhea, the evidence does support a few specific choices. Look for products containing Lactobacillus rhamnosus GG or Saccharomyces boulardii, the two strains with the most consistent research behind them. Aim for a product that lists a CFU count (not just weight) and provides at least 5 billion CFUs per day.
Timing matters. Because most bacterial probiotics are sensitive to the same antibiotics you’re taking, spacing them about two hours apart from your antibiotic dose may help more of the probiotic organisms survive. Start the probiotic at the same time you begin antibiotics, not after you finish the course, since the goal is prevention of diarrhea during treatment.
Keep in mind the trade-off suggested by recent research: probiotics taken after antibiotics may slow the natural rebuilding of your gut’s native bacterial community. If your main concern is long-term gut health rather than preventing diarrhea during treatment, the evidence actually leans toward letting your microbiome recover on its own.